Variable Interval Versus Set Interval Aflibercept for DME
Status:
Completed
Trial end date:
2018-11-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of intravitreal Eylea
injections at a set interval, versus a variable dosing schedule (likely longer than one
month), based on a specific individual's disease progression. There will be approximately 50
men and women at least 18 years of age, diagnosed with type 1 or type 2 diabetes, taking part
in this study at 5 locations in the United States.